Antony Mattessich, Managing Director, Mundipharma International Ltd
“Access to pain treatment is a human right, but still we know that pain disrupts the lives of millions of sufferers and their families across Europe. Pain Alliance Europe is an important initiative to raise the voice of the many people living with pain, and Mundipharma wishes Pain Alliance Europe much success in their hard work to fulfil their mission to improve the quality of life of people living with chronic pain in Europe.”
Dr. Harald F. Stock, CEO Grünenthal
“Millions of people in Europe suffer from chronic pain. However, patients , their relatives and care givers struggle with a disrespect of their suffering by society and health care systems. Often they are faced with limited access to appropriate pain treatment. A strong pain patient representation in Europe is urgently needed. That is why Grünenthal is enthusiastic to hear about the newly formed Pain Alliance Europe (PAE). We wish PAE to become a strong European voice to improve patients’ quality of life and future access to innovative pain care for patients in all of Europe.”
John Young, Regional President, EuCan – Primary Care, Pfizer, Europe, Canada
“As many as 100 million Europeans with chronic pain want to be active members of society, but many feel their condition stands in their way. Progress is only possible through partnership between stakeholders committed to solve this problem together to improve the lives of patients suffering from chronic pain.
As a company long committed to being an active partner in this dialogue, Pfizer welcomes Pain Alliance Europe and looks forward to the strength this collaboration will bring to the voice of chronic pain patients.”